| Time (UTC+8) | Topic / 主題 | Speaker / 講者 | Slides / 簡報 | Online Conference / 線上會議 | |
|---|---|---|---|---|---|
| 17:00 - 17:50 | Abstract oral presentation |
|
|||
| 18:00 - 18:30 | 【TBCS-GBCC Joint Session】Opening |
|
|||
| 18:10 - 18:40 | 【TBCS-GBCC Joint Session】Overcome the gap between the reality and international guideline: Korea’s view |
|
|||
| 18:40 - 19:10 | 【TBCS-GBCC Joint Session】Overcome the gap between the reality and international guideline: Taiwan’s view |
|
|||
| 19:10 - 20:20 | 【TBCS-GBCC Joint Session】Round table discussion |
|
| Time (UTC+8) | Topic / 主題 | Speaker / 講者 | Slides / 簡報 | Online Conference / 線上會議 | |
|---|---|---|---|---|---|
| 08:15 - 08:30 | Opening Remark |
|
|||
| 08:30 - 09:00 | What can we contribute to breast cancer in Taiwan ? | Mien-Chie Hung |
|
||
| 09:00 - 09:30 | New horizon of TNBC: clinical outcomes and perspective of A Novel Trop-2 Antibody-Drug conjugate | Hope S. Rugo |
|
||
| 09:30 - 10:00 | To whom should adjuvant PARP inhibitors be offered? | Charles E. Geyer |
|
||
| 10:00 - 10:30 | Coffee Break |
|
|||
| 10:30 - 11:00 | The changing treatment landscape for HR+HER2-mBC patient with CDKi | Dejan Juric |
|
||
| 11:00 - 11:30 | Treatment options of CDK4&6i, S-1, and PARP-i on HR+ early breast cancer: Japan experience | Hiroko Masuda |
|
||
| 11:30 - 11:50 | Mucinous carcinoma | Yoon-Sim Yap |
|
||
| 11:50 - 12:20 | Metaplatic carcinoma of breast: biology, challenges, and strategic direction | Ching-Hung Lin |
|
||
| 12:20 - 13:00 | 【Luncheon Symposium】Thinking outside of the box? What are the possible options for metastatic breast cancer | Wei-Wu Chen |
|
||
| 13:00 - 13:30 | Break |
|
|||
| 13:30 - 14:00 | Maximizing clinical benefit of atezolizumab in triple negative breast cancer | Chun-Yu Liu |
|
||
| 14:00 - 14:30 | The Benefit of Extended Adjuvant Therapy in HER2+ eBC Patients with High Recurrence Risk | Diana Lüftner |
|
||
| 14:30 - 15:00 | Genetic testing for hereditary breast cancer - what we’ve learned today and what to do tomorrow | Wen-Ling Kuo |
|
||
| 15:00 - 15:30 | Coffee Break |
|
|||
| 15:30 - 16:00 | Raising the bar for patients with HR+/HER2- Early Breast Cancer | Nadia Harbeck |
|
||
| 16:00 - 16:30 | Unsolved questions in CDK4/6i mBC setting | Fatima Cardoso |
|
||
| 16:30 - 17:00 | HER2 dual blockade treatment benefit on eBC patient survival and Singapore experience with FlexCare | Soo Chin Lee |
|
||
| 17:00 - 17:30 | Past, present and future of HER2+ breast cancer treatment | Paul Cornes |
|
| Time (UTC+8) | Topic / 主題 | Speaker / 講者 | Slides / 簡報 | Online Conference / 線上會議 | |
|---|---|---|---|---|---|
| 08:20 - 08:50 | Local-regional management after neoadjuvant therapy | Laura Dominici |
|
||
| 08:50 - 09:20 | Local therapy for the primary site in De Novo Stage IV breast cancer | Seema A. Khan |
|
||
| 09:20 - 09:50 | Recent progress of antibody-drug conjugate in breast cancer treatment | Shanu Modi |
|
||
| 09:50 - 10:20 | Recent advances in Her2 directed therapy in Her2+ ABC | Soo Chin Lee |
|
||
| 10:20 - 10:40 | Coffee Break |
|
|||
| 10:40 - 11:10 | Experience sharing: how do we initiate and conduct large scale IIT | Jee Hyun Kim |
|
||
| 11:10 - 11:40 | Identify unmet needs for improving care for patients with chemotherapy-induced neutropenia | Chi-Cheng Huang |
|
||
| 11:40 - 12:10 | New Strategic Approach of Neoadjuvant in Early Breast Cancer | Chin-Sheng Hung |
|
||
| 12:10 - 12:50 | 【Luncheon Symposium】 Recent Roles of Vacuum assisted breast biopsy in Korea | Sang-Won Kim |
|
||
| 12:50 - 13:10 | Break |
|
|||
| 13:10 - 13:40 | Bone-targeted agents for the management of breast cancer patients with bone metastases | Dwan-Ying Chang |
|
||
| 13:40 - 14:00 | Pseudocirrhosis: a unique presentation of liver metastasis in advanced breast cancer | Wei-Li Ma |
|
||
| 14:00 - 14:20 | Coffee Break |
|
|||
| 14:20 - 14:50 | Neoadjuvant chemotherapy backbone, which is the optimal option? | Sibylle Loibl |
|
||
| 14:50 - 15:20 | The considerations about adjuvant treatment choices after neoadjuvant therapy | Giampaolo Bianchini |
|
||
| 15:20 - 15:50 | Avoiding breast and axillary surgery after neoadjuvant therapy | Joerg Heil |
|
||
| 15:50 - 16:20 | Adjuvant radiotherapy after neoadjuvant treatment | Boon H. Chua |
|
||
| 16:20 - 16:40 | Panel Discussion |
|
|||
| 16:40 - 17:00 | Award Ceremony & Closing |
|